Compound Libraries

- A unique collection of 2240 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. - Targets include MEK, TGF-β, GSK3, wnt, etc. - Structural diversity, significant pharmaceutical efficacy, and cell permeability. - Detailed instructions, compound structures, target information, IC50 values, activity descriptions, etc. - Various assays such as NMR, HPLC/LCMS to ensure the correct structure and high purity of the product and reduce false positives.

- A unique collection of 4880 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); - Targets cover various aging-related processes, such as cell protective, DNA damage repair, and stem cell induction, etc.; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - NMR and HPLC/LCMS validated to ensure high purity and quality;

- A unique collection of 250 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - NMR and HPLC/LCMS validated to ensure high purity and quality;

- A unique collection of 2405 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); - Effective tool for research in functions of the hematologic system and related diseases, such as hemophilia, leukemia, β-thalassemia; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - NMR and HPLC/LCMS validated to ensure high purity and quality;

- A unique collection of 2080 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies； - Covers PI3K-AKT, MAPK, Ubiquitination signaling pathways and targets such as HIF, HIF Prolyl-Hydroxylase, E1/E2/E3 Enzyme, PI3K, MAPK, Proteasome, etc. - Part of them are in clinical trial phase or FDA approved； - Detailed compound information with structure, target, and biological activity description； - NMR and HPLC validated to ensure high purity and quality.

- A unique collection of 210 ubiquitination related small chemicals can be used for high throughput and high content screening； - Targets include proteasome, E1/E2/E3 Enzyme, DUB, p97, etc.; - Detailed compound information with structure, target, and biological activity description； - NMR and HPLC validated to ensure high purity and quality.

- A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study； - Covers various targets such as GPX4, ROS, p53, Nrf2, etc.； - Some compounds are FDA approved; - Detailed compound information with structure, target, and biological activity description； - NMR and HPLC validated to ensure high purity and quality.

- Quantity: 1119 drug fragments，a must-have tool for FBDD; - Physiochemical properties: 53% of fragments are Ro3 compliant，and all fragments matching with approved drugs or clinical compounds will have the best drug potential; - Quality guaranteed: NMR and HPLC/LCMS validated to ensure high purity and quality; - Applicable to various detection methods: suitable for SPR, NMR, and X-ray crystallization screening.

- A unique collection of 2394 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; - Targets include Bcl-2, Caspase, p53, TNF-alpha, and surviving, etc.; - Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality;